玻璃体内注射贝伐单抗治疗脉络膜黑色素瘤近距离放射治疗所致放射性黄斑病变。 - Suppr

Suppr

超能文献

Intravitreal bevacizumab treatment of radiation maculopathy due to brachytherapy in choroidal melanoma.

作者信息

Ziemssen Focke, Voelker Michael, Altpeter Elke, Bartz-Schmidt Karl U, Gelisken Faik

出版信息

Acta Ophthalmol Scand. 2007 Aug;85(5):579-80. doi: 10.1111/j.1600-0420.2007.00899.x. Epub 2007 Feb 27.

DOI:10.1111/j.1600-0420.2007.00899.x

PMID:17324216

Abstract

摘要

相似文献

Intravitreal bevacizumab treatment of radiation maculopathy due to brachytherapy in choroidal melanoma.

Acta Ophthalmol Scand. 2007 Aug;85(5):579-80. doi: 10.1111/j.1600-0420.2007.00899.x. Epub 2007 Feb 27.

Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma.

Retina. 2007 Sep;27(7):903-7. doi: 10.1097/IAE.0b013e31806e6042.

Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin).

Retina. 2008 Jul-Aug;28(7):964-8. doi: 10.1097/IAE.0b013e3181706302.

Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy.

Am J Ophthalmol. 2007 Feb;143(2):335-8. doi: 10.1016/j.ajo.2006.09.014. Epub 2006 Oct 23.

Management of radiation maculopathy.

Ophthalmic Res. 2012;48 Suppl 1:26-31. doi: 10.1159/000339844. Epub 2012 Aug 21.

Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy.

Arch Ophthalmol. 2007 Jun;125(6):751-6. doi: 10.1001/archopht.125.6.751.

INTRAVITREAL DEXAMETHASONE IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO PLAQUE BRACHYTHERAPY IN CHOROIDAL MELANOMA.

Retina. 2015 Sep;35(9):1890-7. doi: 10.1097/IAE.0000000000000537.

Ozurdex(®) reduces the retinal thickness in radiation maculopathy refractory to bevacizumab.

Acta Ophthalmol. 2014 Dec;92(8):e694-6. doi: 10.1111/aos.12424. Epub 2014 Apr 16.

Intravitreal pegaptanib sodium (Macugen) for radiation retinopathy following episcleral plaque radiotherapy.

Acta Ophthalmol. 2008 Sep;86(6):700-1. doi: 10.1111/j.1600-0420.2007.01101.x. Epub 2008 Aug 14.

Intravitreous ranibizumab (lucentis) for radiation maculopathy.

Arch Ophthalmol. 2010 Feb;128(2):249-52. doi: 10.1001/archophthalmol.2009.376.

引用本文的文献

Outcomes of Second-Line Intravitreal Anti-VEGF Switch Therapy in Radiation Retinopathy Secondary to Uveal Melanoma: Moving from Bevacizumab to Aflibercept.

Ocul Oncol Pathol. 2023 Feb;8(4-6):230-235. doi: 10.1159/000526548. Epub 2022 Sep 1.

Hypoxia-dependent drivers of melanoma progression.

J Exp Clin Cancer Res. 2021 May 8;40(1):159. doi: 10.1186/s13046-021-01926-6.

The proliferation of malignant melanoma cells could be inhibited by ranibizumab via antagonizing VEGF through VEGFR1.

Mol Vis. 2014 May 13;20:649-60. eCollection 2014.

Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity.

Clin Ophthalmol. 2012;6:1739-48. doi: 10.2147/OPTH.S34949. Epub 2012 Oct 29.

Bevacizumab and intraocular tumors: an intriguing paradox.

Mol Vis. 2012;18:2454-67. Epub 2012 Oct 5.

Intravitreal bevacizumab: an analysis of the evidence.

Clin Ophthalmol. 2007 Sep;1(3):273-84.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验